News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
791,706 Results
Type
Article (72696)
Company Profile (362)
Press Release (718648)
Multimedia
Podcasts (95)
Webinars (14)
Section
Business (220829)
Career Advice (2965)
Deals (37795)
Drug Delivery (122)
Drug Development (87827)
Employer Resources (187)
FDA (17429)
Job Trends (16420)
News (375396)
Policy (36959)
Tag
Academia (2984)
Academic (2)
Accelerated approval (5)
Adcomms (28)
Allergies (93)
Alliances (54698)
ALS (98)
Alzheimer's disease (1491)
Antibody-drug conjugate (ADC) (148)
Approvals (17404)
Artificial intelligence (289)
Autoimmune disease (25)
Automation (16)
Bankruptcy (391)
Best Places to Work (12506)
BIOSECURE Act (20)
Biosimilars (118)
Biotechnology (243)
Bladder cancer (82)
Brain cancer (31)
Breast cancer (299)
Cancer (2400)
Cardiovascular disease (201)
Career advice (2497)
Career pathing (33)
CAR-T (167)
Cell therapy (465)
Cervical cancer (21)
Clinical research (70863)
Collaboration (906)
Compensation (538)
Complete response letters (27)
COVID-19 (2851)
CRISPR (47)
C-suite (264)
Cystic fibrosis (105)
Data (2254)
Decentralized trials (2)
Denatured (32)
Depression (54)
Diabetes (290)
Diagnostics (6859)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (130)
Drug pricing (125)
Drug shortages (28)
Duchenne muscular dystrophy (101)
Earnings (90068)
Editorial (44)
Employer branding (24)
Employer resources (160)
Events (125229)
Executive appointments (771)
FDA (18738)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (806)
Gene editing (118)
Generative AI (29)
Gene therapy (345)
GLP-1 (822)
Government (5108)
Grass and pollen (6)
Guidances (65)
Healthcare (20685)
Huntington's disease (24)
IgA nephropathy (30)
Immunology and inflammation (141)
Indications (30)
Infectious disease (3009)
Inflammatory bowel disease (150)
Inflation Reduction Act (11)
Influenza (56)
Intellectual property (99)
Interviews (569)
IPO (17198)
IRA (50)
Job creations (4371)
Job search strategy (2068)
Kidney cancer (11)
Labor market (38)
Layoffs (527)
Leadership (23)
Legal (9078)
Liver cancer (81)
Lung cancer (343)
Lymphoma (156)
Machine learning (7)
Management (64)
Manufacturing (329)
MASH (75)
Medical device (14340)
Medtech (14345)
Mergers & acquisitions (21138)
Metabolic disorders (759)
Multiple sclerosis (86)
NASH (23)
Neurodegenerative disease (108)
Neuropsychiatric disorders (32)
Neuroscience (2083)
NextGen: Class of 2025 (7383)
Non-profit (5046)
Now hiring (39)
Obesity (405)
Opinion (261)
Ovarian cancer (78)
Pain (97)
Pancreatic cancer (86)
Parkinson's disease (159)
Partnered (22)
Patents (247)
Patient recruitment (113)
Peanut (51)
People (63198)
Pharmaceutical (82)
Pharmacy benefit managers (20)
Phase I (21976)
Phase II (30914)
Phase III (23150)
Pipeline (1237)
Policy (162)
Postmarket research (3261)
Preclinical (9813)
Press Release (72)
Prostate cancer (112)
Psychedelics (38)
Radiopharmaceuticals (267)
Rare diseases (420)
Real estate (6792)
Recruiting (72)
Regulatory (25049)
Reports (47)
Research institute (2637)
Resumes & cover letters (460)
Rett syndrome (5)
RNA editing (5)
RSV (49)
Schizophrenia (79)
Series A (141)
Series B (91)
Service/supplier (19)
Sickle cell disease (58)
Special edition (17)
Spinal muscular atrophy (163)
Sponsored (32)
Startups (4016)
State (2)
Stomach cancer (16)
Supply chain (74)
Tariffs (44)
The Weekly (61)
Vaccines (797)
Venture capitalists (42)
Weight loss (283)
Women's health (39)
Worklife (20)
Date
Today (176)
Last 7 days (905)
Last 30 days (2795)
Last 365 days (34794)
2025 (11350)
2024 (37267)
2023 (42252)
2022 (53555)
2021 (58300)
2020 (57303)
2019 (50830)
2018 (38595)
2017 (35493)
2016 (35993)
2015 (42374)
2014 (36649)
2013 (32912)
2012 (34659)
2011 (34907)
2010 (33987)
Location
Africa (1059)
Alabama (57)
Alaska (7)
Arizona (259)
Arkansas (14)
Asia (45181)
Australia (8315)
California (6322)
Canada (2046)
China (552)
Colorado (276)
Connecticut (298)
Delaware (154)
Europe (102699)
Florida (929)
Georgia (220)
Hawaii (1)
Idaho (63)
Illinois (601)
India (28)
Indiana (325)
Iowa (11)
Japan (167)
Kansas (108)
Kentucky (25)
Louisiana (12)
Maine (70)
Maryland (945)
Massachusetts (4806)
Michigan (244)
Minnesota (415)
Mississippi (2)
Missouri (91)
Montana (31)
Nebraska (25)
Nevada (65)
New Hampshire (70)
New Jersey (1795)
New Mexico (31)
New York (1809)
North Carolina (1083)
North Dakota (9)
Northern California (2735)
Ohio (215)
Oklahoma (15)
Oregon (38)
Pennsylvania (1407)
Puerto Rico (13)
Rhode Island (35)
South America (1426)
South Carolina (23)
South Dakota (1)
Southern California (2368)
Tennessee (104)
Texas (934)
United States (24226)
Utah (190)
Virginia (159)
Washington D.C. (69)
Washington State (581)
West Virginia (3)
Wisconsin (66)
791,706 Results for "syneos health formerly known as inc research inventiv health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Venture capitalists
Bausch Health Tussles With Activist Investor Carl Icahn After Popping Poison Pill
Bausch Health has launched a shareholder rights plan—also known as a poison pill defense—designed to prevent any one entity from taking control of the company to the detriment of other shareholders.
April 23, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Alimentiv and Dova Health Intelligence (Previously Satisfai Health Inc.) Launch an AI Solution for Scoring of Ulcerative Colitis (UC) at DDW 2025 in San Diego
May 1, 2025
·
3 min read
IN PARTNERSHIP WITH DIA
Economic Challenges, Strategic Investments: Reshaping the Women’s Health Landscape
In this episode presented by DIA, BioSpace’s head of insights Lori Ellis discusses how collaboration and investment shape the the future of women’s health with Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives at the National Academy of Medicine.
April 24, 2025
·
1 min read
·
Lori Ellis
Government
Democrats Push Back on Trump Health Cuts With Lawsuits and Longest Ever Senate Speech
Nearly two dozen states on Tuesday sued the Department of Health and Human Services over a planned $11 billion funding cut for public health projects while New Jersey Senator Cory Booker spoke for 25 hours in protest of Trump administration policies.
April 2, 2025
·
2 min read
·
Tristan Manalac
Press Releases
GI Alliance and Iterative Health Partner to Advance GI Clinical Research in the Community
April 23, 2025
·
3 min read
Press Releases
Fellow Health to Present Innovative Research on Prostate Cancer Biomarkers and PVSA Testing at AUA 2025
April 28, 2025
·
3 min read
Press Releases
Penumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference
April 29, 2025
·
1 min read
Business
“Perfect Patient” Industry Burdens; Exits and Investment in Women’s Health
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis and Miruna Sasu, CEO of COTA, discuss the challenges of inclusion and exclusion criteria of clinical trial patients, and reflect on current investment approaches around women’s health.
March 13, 2025
·
1 min read
·
Lori Ellis
Pharm Country
New CHOP Research Links Genetics, Environment and Health Disparities to Increased Stress and Mental Health Challenges During Adolescence
A new study from researchers at Children’s Hospital of Philadelphia reveals that the cumulative “wear and tear” on the body known as allostatic load can be measured in early adolescence and that childhood adversity correlates with increased stress and mental health challenges during adolescence.
May 14, 2024
·
4 min read
Lone Star Bio
Elligo Health Research Announces Expansion of Study Marketplace With Syneos Health
Elligo Health Research®, the largest healthcare-enabling research organization, announced it is expanding its Study Marketplace platform with Syneos Health, a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success.
October 5, 2023
·
2 min read
1 of 79,171
Next
